# Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject

> **NCT04988646** · NA · COMPLETED · sponsor: **PT. Kimia Farma (Persero) Tbk** · enrollment: 56 (actual)

## Conditions studied

- Drug Use

## Interventions

- **DRUG:** Acyclovir 200 MG
- **DRUG:** Acyclovir 400 MG
- **DRUG:** Zovirax 200 MG Tablet
- **DRUG:** Zovirax 400 MG Tablet

## Key facts

- **NCT ID:** NCT04988646
- **Lead sponsor:** PT. Kimia Farma (Persero) Tbk
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-21
- **Primary completion:** 2020-04-20
- **Final completion:** 2020-04-28
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04988646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04988646, "Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04988646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*